Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Hilscher

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|October 30, 2023
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin DeacetylationLaura Sinatra, Anja Vogelmann, Florian Friedrich, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatmentKaroline B Waitman, Holli-Joi Martin, Jorge A E G Carlos, et al.
Computers in Biology and Medicine|August 29, 2025
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatmentKaroline B Waitman, Holli-Joi Martin, Jorge A E G Carlos, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Scientific Reports|November 29, 2023
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitorsMaurício T Tavares, Arne Krüger, Sun L Rei Yan, et al.
Nature Communications|July 2, 2024
Epigenetic-based differentiation therapy for Acute Myeloid LeukemiaEdurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|October 30, 2023
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin DeacetylationLaura Sinatra, Anja Vogelmann, Florian Friedrich, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatmentKaroline B Waitman, Holli-Joi Martin, Jorge A E G Carlos, et al.
Computers in Biology and Medicine|August 29, 2025
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatmentKaroline B Waitman, Holli-Joi Martin, Jorge A E G Carlos, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Scientific Reports|November 29, 2023
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitorsMaurício T Tavares, Arne Krüger, Sun L Rei Yan, et al.
Nature Communications|July 2, 2024
Epigenetic-based differentiation therapy for Acute Myeloid LeukemiaEdurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, et al.
Pageof 2